Related Experiment Video
Updated: May 30, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Epidemiologic and therapeutic status study of patients with hepatitis C]
Min Xu1, Hai-yan Shi, Wei-ping Cai
1Guangzhou Eighth Municipal People's Hospital, Guangzhou 510060, China. xumindoctor@163.net
Insights
Most hepatitis C infections stem from blood transfusions, with diagnosis often delayed over 15 years post-infection. Treatment also faces significant delays, impacting patient outcomes.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Context:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Understanding transmission routes and disease progression is crucial for effective management.
- Delayed diagnosis and treatment contribute to increased morbidity and mortality.
Purpose:
- To analyze the primary modes of hepatitis C virus (HCV) infection.
- To determine the time intervals between infection, diagnosis, and treatment for HCV patients.
- To identify patterns in diagnostic and treatment delays for hepatitis C.
Summary:
- Retrospective analysis of 216 hepatitis C patients (2004-2009) revealed post-transfusion hepatitis C (PTHC) as the predominant infection route (72.22%).
- A significant proportion of patients (32.61%) were diagnosed 15-20 years after infection, with some diagnosed over 20 years later (3.26%).
- Treatment delays were common, with 33.80% treated over 5 years post-diagnosis and 17.13% treated 10-15 years later.
Impact:
- Highlights the critical need for improved screening of blood products to prevent transfusion-transmitted hepatitis C.
- Underscores the importance of early hepatitis C detection and prompt treatment initiation to mitigate long-term complications.
- Informs public health strategies for hepatitis C prevention and management, emphasizing timely interventions.
Objective:
To investigate the different infective mode, the time from be infectived to be diagnosed and the time from be diagnosed to be treated of patients with hepatitis C.
Methods:
The different infective mode, the time from be infectived to be diagnosed and the time from be diagnosed to be treated of 216 patients with hepatitis C from march 2004 to march 2009 were retrospectively analyzed.
Results:
72.22 percents patients suffered from post transfusion hepatitis C (PTHC) and 27.78 percents patients suffered from sporadic hepatitisC (SHC). 32.61 percents patients were diagnosed after be infectived 15-20 years later. 3.26 percents patients were diagnosed after be infectived more than 20 years later. 33.80 percents patients were treated after be diagnosed more than 5 years later. 17.13 percents patients were treated after be diagnosed 10-15 years later.
Conclusion:
Most patients were infectived with hepatitis C by transfusing blood or blood products. Most patients were diagnosed after be infectived more than 15 years later. Almost half of patients were treated after be diagnosed more than 5 years later, and a significant portion of percents patients were treated after be diagnosed more than 10 years later.
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment